Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Prognostic Significance of Histological Subtypes in Patients with Muscle-Invasive Bladder Cancer: An Overview of the Current Literature
Francesco Claps, Arianna Biasatti, Luca Di Gianfrancesco, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 15, pp. 4349-4349
Open Access | Times Cited: 15

Showing 15 citing articles:

Prognostic role of prognostic nutritional index in patients with bladder cancer: a systematic review and meta-analysis
Jing Sun, Zhenzhen Li, Xiaming Zhu
Frontiers in Oncology (2025) Vol. 14
Open Access
PRR11 Promotes Bladder Cancer Growth and Metastasis by Facilitating G1/S Progression and Epithelial‐Mesenchymal Transition
Lu Wang, Zengshun Kou, Jiaxi Zhu, et al.
Cancer Medicine (2025) Vol. 14, Iss. 5
Open Access
Using machine learning for predicting cancer-specific mortality in bladder cancer patients undergoing radical cystectomy: a SEER-based study
Lei Dai, Kun Ye, G YAO, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Treatment Patterns and Radical Cystectomy Outcomes in Patients Diagnosed With Urothelial Nonmetastatic Muscle‐Invasive Bladder Cancer in the United States
B Davies-Teye, M. Minhaj Siddiqui, Xiao Zhang, et al.
Cancer Medicine (2025) Vol. 14, Iss. 4
Open Access
Efficacy and safety of the first-line systemic treatments in patients with advanced-stage urothelial carcinoma: a systematic review and network meta-analysis
Yang Zhao, Xiaoqing Xu, Yuhan Sun, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Prognostic evaluation of segmental ureterectomy combined with chemotherapy in high-grade non-metastatic ureteral cancer: a study based on the SEER database
Yu Xia, Binbin Ma, Mengyun Li, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Kidney-Sparing Management of UTUC in Solitary Kidney Patients: A Retrospective Analysis and Narrative Review
Angelis Peteinaris, Spyridon Polyzonis, Vasileios Tatanis, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 22, pp. 6788-6788
Open Access
Artificial Intelligence can Facilitate Application of Risk Stratification Algorithms to Bladder Cancer Patient Case Scenarios
Max Yudovich, Ahmad N. Alzubaidi, Jay D. Raman
Clinical Medicine Insights Oncology (2024) Vol. 18
Open Access
Association between tumor size and prognosis in bladder cancer: novel classifications and insights from a SEER database analysis
Yige Jia, Kan Wu, Xiang Li
Frontiers in Surgery (2024) Vol. 11
Open Access
Evolving Treatment Landscape of Frontline Therapy for Metastatic Urothelial Carcinoma: Current Insights and Future Perspectives
Whi‐An Kwon, Min-Kyung Lee
Cancers (2024) Vol. 16, Iss. 23, pp. 4078-4078
Open Access
Efficacy and safety of first-line immunotherapy-containing regimens compared with chemotherapy for advanced or metastatic urothelial carcinoma: a network meta-analysis of randomized controlled trials
Weiming Liang, Shibo Huang, Yanping Huang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
CD105-microvessel density analysis and its clinical value in urothelial carcinoma of bladder patients
Rohit Siddhartha, Atin Singhai, Apul Goel, et al.
Biomarkers (2024), pp. 1-14
Closed Access
Prognostic value of the triglyceride—glucose index in non-muscle-invasive bladder cancer: a retrospective study
Yan Zhang, Xianfeng Shao, Li Ding, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access
Systemic induction therapy in patients with locally advanced or node-positive urothelial carcinoma: Evaluating treatment outcomes
Vera C Rutten, Jan-Jaap J. Mellema, Tahlita C.M. Zuiverloon, et al.
Bladder Cancer (2024) Vol. 10, Iss. 4, pp. 251-263
Open Access
Physiological markers for immunotherapeutics: a review
Durlav Chowdhury, Ashmita Das, Mrityunjay Mishra, et al.
Journal of Chemotherapy (2024), pp. 1-24
Closed Access
Association Between Baseline and Changes in Early Neutrophil-to-Lymphocyte Ratio on Survival in Patients with Metastatic Bladder Carcinoma Treated with Immunotherapy
Ezgi Değerli, Çağatay Arslan, Fatih Selçukbırıcık, et al.
Medicina (2024) Vol. 60, Iss. 12, pp. 2103-2103
Open Access
Page 1

Scroll to top